Cart
sales@molnova.com
SAR125884 hydrochlorid
CAS No. ——
SAR125884 hydrochlorid ( —— )
Catalog No. M20372 CAS No. ——
SAR125844 is a potent and selective MET kinase inhibitor with a favorable preclinical toxicity profile(IC50=4.2 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 101 | Get Quote |
|
| 10MG | 168 | Get Quote |
|
| 25MG | 361 | Get Quote |
|
| 50MG | 687 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSAR125884 hydrochlorid
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAR125844 is a potent and selective MET kinase inhibitor with a favorable preclinical toxicity profile(IC50=4.2 nM).
-
DescriptionSAR125844 is a potent and selective MET kinase inhibitor with a favorable preclinical toxicity profile(IC50=4.2 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
RecptorMET RTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight550.6
-
Molecular FormulaC25H23FN8O2S2?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Fc1ccc(cc1)-c1ccc2nnc(Sc3ccc4nc(NC(=O)NCCN5CCOCC5)sc4c3)n2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in MET-Amplified Cancer[J]. Molecular Cancer Therapeutics 2015 14(2):384-394.
molnova catalog
related products
-
AMG-337
AMG-337 is a potent and selective inhibitor of MET with biochemical IC50 of 1 nM; inhibits of HGF-mediated MET phosphorylation in PC3 cells.
-
Cabozantinib hydroch...
Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2 c-Met Kit Axl and Flt4 (IC50s: 0.035 1.3 4.6 7 and 6 nM).
-
LMTK3-IN-1
Lmtk3-in-1 is a potent ATP-competitive lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM) inhibitor that degrades LMTK3 through the ubiquitin proteasome pathway.
